Biosilicification in monocots: Comparative analysis highlights contrasting patterns of deposition
Abstract
Abstract Premise New insights into biomineral uptake and sequestration are important for understanding how plants grow. Some plants accumulate silica accretions in precise locations in particular cells. Among monocots, controlled biosilicification occurs in several different forms and is restricted to commelinids and orchids. Methods We utilized energy‐dispersive x‐ray spectroscopy (EDX/EDS) mapping technology on leaf transverse sections to explore the diverse silica deposition patterns in a range of monocots. The results were evaluated using character optimizations on existing phylogenies. Results Our optimization indicates at least two independent evolutionary origins of phytoliths among monocots, with secondary losses in some lineages. Silica that accumulates in the cell lumen occurs mostly in bundle sheath cells or epidermal cells, often associated with sclerenchyma. In Bromeliaceae and Rapateaceae, small phytoliths occur in the walls of occluded epidermal cells overlying sclerenchyma. In Dasypogonaceae, phytoliths accumulate in the lumen of epidermal cells. Cell‐wall bound silica occurs in the epidermal cells of some commelinids (Commelinaceae, Cyperaceae and Poaceae). There is a close association between silica deposition and the presence of ferulic acid, except possibly in orchids. Records of high silica concentration in leaves are not always correlated with deposition. We found no silica deposition in leaves of some aquatic commelinids, despite evidence for silica…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.